Attached files

file filename
EX-32.2 - CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh322.htm
10-K - AOXING PHARMACEUTICAL COMPANY, INC. 10K 2015-06-30 - AOXING PHARMACEUTICAL COMPANY, INC.aoxing.htm
EX-21.1 - LIST OF SUBSIDIARIES - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh211.htm
EX-32.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh312.htm
Exhibit 23


 
Consent of Independent Registered Public Accounting Firm
 

 
The Board of Director and Stockholders
Aoxing Pharmaceutical Company, Inc.

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-205148) and in the Registration Statement on Form S-8 (No. 333-177641) of Aoxing Pharmaceutical Company, Inc. of our report dated October 9, 2015, relating to the consolidated financial statements of Aoxing Pharmaceutical Company, Inc. which appear in this Annual Report on Form 10-K.

/s/ BDO China Shu Lun Pan Certified Public Accountants
BDO China Shu Lun Pan Certified Public Accountants

Shanghai, People’s Republic of China
October 13, 2015